Authors: Jimenez, RE Hussain, M Bianco, FJ Vaishampayan, U Tabazcka, P Sakr, WA Pontes, JE Wood, DP Grignon, DJ

Citation: Re. Jimenez et al., Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic significance and comparative analysis in primary and metastatic tumors, CLIN CANC R, 7(8), 2001, pp. 2440-2447

Authors: Hussain, M Vaishampayan, U Du, W Redman, B Smith, DC

Citation: M. Hussain et al., Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer, J CL ONCOL, 19(9), 2001, pp. 2527-2533

Authors: Vaishampayan, U Flaherty, L Du, W Hussain, M

Citation: U. Vaishampayan et al., Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acidin advanced renal cell carcinoma, CANCER, 92(3), 2001, pp. 519-523

Authors: Vaishampayan, U Glode, M Du, W Kraft, A Hudes, G Wright, J Hussain, M

Citation: U. Vaishampayan et al., Phase II study of dolastalin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma (vol 6, pg 4205, 2000), CLIN CANC R, 6(12), 2000, pp. 4967-4967

Authors: Vaishampayan, U Glode, M Du, W Kraft, A Hudes, G Wright, J Hussain, M

Citation: U. Vaishampayan et al., Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma, CLIN CANC R, 6(11), 2000, pp. 4205-4208

Authors: Vaishampayan, U Parchment, RE Jasti, BR Hussain, M

Citation: U. Vaishampayan et al., Taxanes: An overview of the pharmacokinetics and pharmacodynamics, UROLOGY, 54(6A), 1999, pp. 22-29